Intrauterine growth restriction (IUGR) is associated with significantly increased perinatal morbidity and mortality as well as cardiovascular disease and glucose intolerance in adult life. A number of disorders from genetic to metabolic, vascular, coagulative, autoimmune, as well as infectious, can influence fetal growth by damaging the placenta, leading to IUGR as a result of many possible fetal, placental and maternal disorders. Strict definitions of IUGR and of its severity are needed in order to eventually distinguish among different phenotypes, such as gestational age at onset, degree of growth restriction and presence of hypoxia. This report explores and reviews some of the most recent developments in both clinical and basic research on intrauterine growth restriction, by seeking mechanisms that involve genetic factors, utero-placental nutrient availability and vascular growth factors. New exciting findings on the genomic imprinting defects potentially associated with IUGR, and the placental anomalies associated with the decreased nutrient transport are summarized. Moreover, recent data on angiogenic growth factors as well as new information arising from application of gene chip technologies are discussed.
Fetal growth restriction : a workshop report / I. Cetin, J.M. Foidart, M. Miozzo, T. Raun, T. Jansson, V. Tsatsaris, W. Reik, J. Cross, S. Hauguel-de-Mouzon, N. Illsley, J. Kingdom, B. Huppertz. - In: PLACENTA. - ISSN 0143-4004. - 25:8-9(2004), pp. 753-757.
|Titolo:||Fetal growth restriction : a workshop report|
CETIN, IRENE (Primo)
|Parole Chiave:||Fetal growth|
|Settore Scientifico Disciplinare:||Settore MED/09 - Medicina Interna|
|Data di pubblicazione:||2004|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1016/j.placenta.2004.02.004|
|Appare nelle tipologie:||01 - Articolo su periodico|